Researchers at Children's Hospital of Pittsburgh of UPMC identified a gene mutation that can be used to pinpoint transplant patients who are likely to reject donated organs. The discovery could aid in the development of personalized organ-rejection drugs as well as improve postsurgery outcome and quality of life among children with liver transplants, a study author said.

Related Summaries